Tag Archives: Pfizer

GSK Scores High in Market Access

GlaxoSmithKline ranked number one in a study of pharmaceutical companies offering access to medicines to emerging and developing nations, proving that the UK drug giant has a far stronger grasp on new markets than its US and Japanese counterparts. The study ranks 20 companies based on significant criteria including pricing, patents and intellectual properties, capacity enhancement, [...]
Posted in Emerging Markets, Strategy | Also tagged , , , , , , | Leave a comment

Pharma Digital Smarts Quantified in IQ Index

Pfizer’s Viagra and AstraZeneca’s (AZ) Nexium took the top two slots on a new Digital IQ Index measuring the digital competence of 51 pharma brands across eight therapeutic categories. The ranking, created by think tank L2 in partnership with media agency PHD Network, evaluated brands’ digital presence across four criteria: platform (including site effectiveness and [...]
Posted in E-Media | Also tagged , , , , , , , , | 1 Comment

Judgment Day for Pfizer Factories

For once, pharma sales reps and R&D guys can breathe a sigh of relief. The latest round of industry layoffs comes from Pfizer, but this time it will affect the manufacturing force, which will be downsized by 6,000 employees by 2015. In 2006, the company announced plans to save $4 billion to $5 billion, and after [...]
Posted in Europe, Global, Manufacturing, News, Strategy | Also tagged , , , , , | Leave a comment

A Crash Course in SaaS

Image via Wikipedia Our magazine is called Pharmaceutical Executive—indicating a focus on the c-suite. But we know many of our readers aren’t executives (yet), and may not have quite the same in-depth knowledge as their bosses. So, for those who hear the term “SaaS” bandied about in conversations and fake their way through discussions about it [...]
Posted in Strategy | Also tagged , , , , , , | Leave a comment

Pfizer NYC Tower Up For Sale

Image by Getty Images via Daylife Pfizer’s New York tower is on the market, but the pharma giant is not planning on leaving Manhattan. The New York Times, on Tuesday, reported that the company is willing to put millions of dollars in tax breaks on the line to consolidate its New York offices. “We are looking [at selling] [...]
Posted in Strategy | Also tagged , , , | Leave a comment